Got Equities? An Unfulfilled Opportunity for P&C Companies to Improve Ratings and Long-Term Financial Performance

W Poutsiaka, L Pohlman, P Pollard - The Journal of Investing, 2009 - pm-research.com
A primary reason that insurance companies allocate very small portions of their portfolios to
equities is the concern that even modest allocations will reduce their ratings. This article …

The Lipid Content of Arctic Mammals

JW Poutsiaka - 1949 - search.proquest.com
… John William Poutsiaka, the son of Daphne Kifsian and William Poutsiaka was born in
Newark, New Jersey on February 6, 1925. He attended Barringer High School in Newark, New …

The trend towards transparency and technology

AH Oshins - Risk Management, 1994 - go.gale.com
… Given that the loss values in hurricane areas have increased sixfold, an emphasis should
be placed on structural design, according to William Poutsiaka, president and CEO of …

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

DD Poutsiaka, D Munson, LL Price, GW Chan… - Bone marrow …, 2011 - nature.com
Blood stream infection (BSI) and acute GVHD (aGVHD) are serious complications of
hematopoietic SCT (HSCT). We hypothesized that the two events were not independent of one …

Prospective observational study comparing sepsis-2 and sepsis-3 definitions in predicting mortality in critically ill patients

DD Poutsiaka, MC Porto, WA Perry… - Open forum …, 2019 - academic.oup.com
Background Sepsis definitions have evolved, but there is a lack of consensus over adoption
of the most recent definition, Sepsis-3. We sought to compare Sepsis-2 and Sepsis-3 in the …

Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis

DD Poutsiaka, LE Davidson, KL Kahn… - … journal of infectious …, 2009 - Taylor & Francis
Few studies have focused on sepsis in patients with pre-existing immunosuppression. Since
the numbers and the incidence of sepsis are increasing, sepsis in immunosuppressed …

1374: UTILITY OF PRESEPSIN IN DISTINGUISHING SEPSIS FROM SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

J Hudcova, D Poutsiaka, M Khan, A Waqas… - Critical Care …, 2016 - journals.lww.com
Methods: This was an IRB approved two center prospective observational study enrolling
patients≥ 21 years within 18 hours of meeting SIRS criteria (baseline). Presepsin and …

Problems in predicting drug effects across species lines

CG Smith, JW Poutsiaka… - Journal of International …, 1973 - journals.sagepub.com
During the course of drug development, there are many instances where extrapolation of data
from animals to man is difficult because the toxicologic and metabolic responses induced …

Inhibition of angiotensin I-initiated hemodynamic changes in anesthetized dogs by a synthetic nonapeptide

…, GL Hassert Jr, JW Poutsiaka - Proceedings of the …, 1972 - journals.sagepub.com
Intravenous injections of SQ 20, 881, a competitive inhibitor of the angioten-sin-converting
enzyme, suppressed the pressor and reduced renal blood flow responses initiated by the …

Babesiosis

JA Gelfand, DD Poutsiaka - Principles and Practise of Clinical …, 2001 - Wiley Online Library
Infection by the malaria‐like protozoan, Babesia, has been recognised for over 100 years.
Babesiosis, also known as piroplasmosis, was considered a disease of animals, affecting …